Skip to content

Carbohydrate-restricted diet in inflammatory bowel disease

Investigating the effect of modified specific carbohydrate diet on nutritional status, disease and quality of life in patients with ulcerative colitis

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170202032367N7
Enrollment
42
Registered
2023-03-01
Start date
2023-04-22
Completion date
Unknown
Last updated
2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease (ulcerative colitis). K51

Interventions

Intervention 1: Intervention group:People in the intervention group will receive a modified specific carbohydrate diet and essential tips during the diet to follow for 6 weeks. Intervention 2: Control

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age above 20 and less than 60 years Patients with mild to moderate ulcerative colitis Willingness to participate in the study

Exclusion criteria

Exclusion criteria: Changing the type of medicine used and its dosage during the last month Having other intestinal diseases (malignancies, infectious diseases) Suffering from other inflammatory diseases and kidney diseases and diabetes Pregnancy or breastfeeding Use of antibiotics, or use of pre- or probiotic products, or use of multivitamin and mineral supplements, or use of anti-inflammatory supplements such as w3 and curcumin during the intervention and in the one-month period before the intervention. Smoking and drug use History of hospitalization during the last three months

Design outcomes

Primary

MeasureTime frame
Nutritional status. Timepoint: Before the intervention and 6 weeks later. Method of measurement: Anthropometric measurements including weight, height, and BMI calculation will be done and will be included in the questionnaire.;Inflammation. Timepoint: Before the intervention and 6 weeks later. Method of measurement: Eliza kit.;Quality of Life. Timepoint: Before the intervention and 6 weeks later. Method of measurement: Inflammatory bowel disease questionnaire.

Secondary

MeasureTime frame
Complete blood cell count. Timepoint: Before the intervention and 6 weeks later. Method of measurement: Auto Analyzer device.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHelia Moharrami

Tehran University of Medical Sciences

misshelia.1515@gmail.com+98 990 445 4402

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026